Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06617013 · ClinicalTrials.gov registry record · NA
GERD in Children With Cystic Fibrosis
A NA study of Cystic Fibrosis in Children and GERD in Children, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06617013 is a NA study of Cystic Fibrosis in Children and GERD in Children that is actively recruiting participants, run by Duke University. The registered enrollment target is 20 participants, below the 87-participant average among 6 other Cystic Fibrosis in Children trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06617013, a NA study of Cystic Fibrosis in Children and GERD in Children, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal Symptom Assessment Scale (GSAS) and the impact of stopping anti-GERD therapy on the GERD symptoms reported.
Conditions Studied
Interventions
- OTHER Discontinuation of GERD therapy
Study Locations (1)
North Carolina
- Duke University Hospital - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-10-23 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06617013
The ClinicalTrials.gov registry entry for NCT06617013 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 87-participant average among 6 other Cystic Fibrosis in Children trials with a reported enrollment target (77% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cystic Fibrosis in Children appearing as the primary indexed condition, and to 1 intervention - of which Discontinuation of GERD therapy is the first listed.
NCT06617013 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06617013 about?
NCT06617013 is a clinical study titled "GERD in Children With Cystic Fibrosis". The purpose of this study is to evaluate the prevalence of gastroesophageal reflux disease (GERD) symptoms in pediatric patients with cystic fibrosis using the Gastroesophageal Symptom Assessment Scale (GSAS) and the impact of stopping anti-GERD therapy on the GERD symptoms reported.
What is the current status of trial NCT06617013?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-10-23. Estimated completion is 2026-06-30.
What conditions does trial NCT06617013 study?
This clinical trial studies the following conditions: Cystic Fibrosis in Children, GERD in Children.
What interventions are being tested in trial NCT06617013?
The interventions under investigation include: Discontinuation of GERD therapy (OTHER).
Who is sponsoring clinical trial NCT06617013?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06617013 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of a Mobile Medication Plan Application in CF Patient Care
COMPLETED · NA
-
Feasibility of Cough Monitoring in Children
RECRUITING
-
Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis
RECRUITING
-
Sinus Disease in Young Children With Cystic Fibrosis
RECRUITING
-
19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease
RECRUITING
-
The PROMISE Pediatric Study 6 to 11 Years Old
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.